Testing effectiveness (Phase 2)Study completedNCT02553343
What this trial is testing
The Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 792